Hims Hers Health is trading 4% up at $32.06 as investors extend a rebound from the recent selloff triggered by an FTC health data privacy complaint.

  • The move follows a strong 10.4% gain on August 3, 2026, as traders continue to buy the dip following the sharp decline on July 29.
  • Broader U.S. equity markets are also trading sharply higher today, providing additional momentum for the stock's recovery.